Evidence map›Paper›PMID 33168061›Full record

ArticleBMC endocrine disorders2020

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Tania Mayvel Espinosa Reyes, Teresa Collazo Mesa, Paulina Arasely Lantigua Cruz, Adriana Agramonte Machado, Emma Domínguez Alonso, Henrik Falhammar

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Long-Term Outcomes of Congenital Adrenal Hyperplasia.Endocrinology and metabolism (Seoul, Korea) · 2022
    Review
  5. Article
  6. Compendium of causative genes and their encoded proteins for common monogenic disorders.Protein science : a publication of the Protein Society · 2022
    Article
  7. Article
  8. Article
  9. Avicenna journal of medical biotechnology
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tania Mayvel Espinosa ReyesNational Institute of Endocrinology, Zapata Street and D, Vedado, 10400, Havana, Cuba. tania.espinosa@infomed.sld.cu.ORCID http://orcid.org/0000-0001-6979-1291
Teresa Collazo MesaNational Institute of Endocrinology, Zapata Street and D, Vedado, 10400, Havana, Cuba.
Paulina Arasely Lantigua CruzNational Center for Medical Genetics, Havana, Cuba.
Adriana Agramonte MachadoNational Center for Medical Genetics, Havana, Cuba.
Emma Domínguez AlonsoNational Institute of Endocrinology, Zapata Street and D, Vedado, 10400, Havana, Cuba.
Henrik FalhammarDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Cuban Neuroscience Center · CUInstituto de Gastroenterología · CUKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital adrenal hyperplasia (CAH) is an autosomal recessive group of diseases. 21-Hydroxylase deficiency (21OHD) accounts for between 95 and 99% of all CAH cases.

objectivesTo characterize the genotype of patients clinically diagnosed with 21OHD and to identify the most frequent mutations in the Cuban population.

methodsCross-sectional descriptive study that included all patients diagnosed with 21OHD from January 2000 to December 2018. For the molecular analysis of the CYP21A2 gene, a protocol was used that used the polymerase chain reaction in 2 stages; in the first stage genomic DNA was amplified and 5 point mutations were detected in the second stage (Intron 2, Deletion of 8 bp, G318X, I172N and P30L).

resultsThe 5 point mutations were identified in 31 of the 55 (56%) studied patients, 16/21 (76%) in the salt-wasting, 12/18 (67%) in the simple virilizing and 3/16 (19%) in the nonclassical form. The Intron 2 mutation was the most frequent, followed by G318X and 8 bp deletion. Compound heterozygotes were found in 10 patients, all corresponded to classic forms of the disease.

conclusionsThe causal CYP21A2 gene mutation was detected in 56% (72% in classic CAH), which makes the method encouraging. The most frequent mutations observed were Intron 2 and G318X. The detection of mutations offers confirmation of diagnosis, prediction of phenotype and genetic counseling.

Indexed as

MutationPhenotypeAdrenal Hyperplasia, CongenitalBiomarkersCross-Sectional StudiesFemaleFollow-Up StudiesGenotypeHumansInfantInfant, NewbornMalePrognosisSteroid 21-HydroxylaseBiomarkersCYP21A2 protein, humanSteroid 21-HydroxylaseCongenital adrenal hyperplasiaGeneticsPoint mutations

Identifiers

PMID33168061
PMCPMC7653887
OpenAlexW3099940023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.